EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $577,543 | -5.6% | 65,112 | +30.2% | 0.01% | -16.7% |
| Q3 2022 | $612,000 | -18.4% | 49,999 | -21.1% | 0.01% | 0.0% |
| Q2 2022 | $750,000 | -27.9% | 63,399 | +16.0% | 0.01% | 0.0% |
| Q1 2022 | $1,040,000 | -8.5% | 54,660 | +27.8% | 0.01% | 0.0% |
| Q4 2021 | $1,136,000 | -5.1% | 42,769 | +46.8% | 0.01% | -14.3% |
| Q3 2021 | $1,197,000 | -46.8% | 29,141 | -26.6% | 0.01% | -46.2% |
| Q2 2021 | $2,248,000 | +44.0% | 39,693 | +6.8% | 0.01% | +30.0% |
| Q1 2021 | $1,561,000 | -31.7% | 37,169 | -48.3% | 0.01% | -33.3% |
| Q3 2018 | $2,287,000 | -4.7% | 71,863 | +7.2% | 0.02% | -6.2% |
| Q2 2018 | $2,401,000 | +29.6% | 67,036 | +20.0% | 0.02% | +220.0% |
| Q1 2018 | $1,852,000 | -20.1% | 55,882 | -26.0% | 0.01% | 0.0% |
| Q4 2017 | $2,319,000 | – | 75,480 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |